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Abstract
Objective To determine if rapid rather than standard intravenous
rehydration results in improved hydration and clinical outcomes when
administered to children with gastroenteritis.
Design Single centre, two arm, parallel randomised pragmatic controlled
trial. Blocked randomisation stratified by site. Participants, caregivers,
outcome assessors, investigators, and statisticians were blinded to the
treatment assignment.
Setting Paediatric emergency department in a tertiary care centre in
Toronto, Canada.
Participants 226 children aged 3 months to 11 years; complete follow-up
was obtained on 223 (99%). Eligible children were aged over 90 days,
had a diagnosis of dehydration secondary to gastroenteritis, had not
responded to oral rehydration, and had been prescribed intravenous
rehydration. Children were excluded if they weighed less than 5 kg or
more than 33 kg, required fluid restriction, had a suspected surgical
condition, or had an insurmountable language barrier. Children were
also excluded if they had a history of a chronic systemic disease,
abdominal surgery, bilious or bloody vomit, hypotension, or
hypoglycaemia or hyperglycaemia.
Interventions Rapid (60 mL/kg) or standard (20 mL/kg) rehydration with
0.9% saline over an hour; subsequent fluids administered according to
protocol.
Main outcome measures Primary outcome: clinical rehydration,
assessed with a validated scale, two hours after the start of treatment.
Secondary outcomes: prolonged treatment, mean clinical dehydration
scores over the four hour study period, time to discharge, repeat visits
to emergency department, adequate oral intake, and physician’s comfort
with discharge. Data from all randomised patients were included in an
intention to treat analysis.
Results 114 patients were randomised to rapid rehydration and 112 to
standard. One child was withdrawn because of severe hyponatraemia
at baseline. There was no evidence of a difference between the rapid
and standard rehydration groups in the proportions of participants who
were rehydrated at two hours (41/114 (36%) v 33/112 (30%); difference
6.5% (95% confidence interval −5.7% to 18.7%; P=0.32). The results
did not change after adjustment for weight, baseline dehydration score,
and baseline pH (odds ratio 1.8, 0.90 to 3.5; P=0.10). The rates of
prolonged treatment were similar (52% rapid v 43% standard; difference
8.9%, 21% to −5%; P=0.19). Although dehydration scores were similar
throughout the study period (P=0.96), the median time to discharge was
longer in the rapid group (6.3 v 5.0 hours; P=0.03).
Conclusions There are no relevant clinical benefits from the
administration of rapid rather than standard intravenous rehydration to
haemodynamically stable children deemed to require intravenous
rehydration.
Trail registration Clinical Trials NCT00392145.
Introduction
Gastroenteritis remains a disease of major importance in public
health.
1 Although oral rehydration is appropriate for most
children,manyreceiveprolongedintravenousrehydration,which
contributes to overcrowding in the emergency department.
2
Given the safety of replacing fluid deficits over 24 hours in
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Research
RESEARCHhaemodynamically stable children, traditional teaching and the
National Patient Safety Agency
3 have advocated such an
approach. Experts have noted, however, that there is a disparity
between the slow restoration regimens recommended and the
rapid rehydration regimens used by clinicians treating
dehydration.
4 The latter has the potential to reduce a child’s
level of agitation and clinical signs of dehydration, in addition
to enhancing alertness and appetite.
4 These potential benefits
might enable clinicians to achieve earlier rehydration with
subsequent reductions in length of stay and costs.
5 A review of
rapid intravenous rehydration studies concluded that evidence
ofefficacyislacking.
6Thusgastroenteritistreatmentguidelines
aimed at developed countries, where severe dehydration is
uncommon, rarely provide a detailed rapid rehydration
strategy.
1 7 8
Because of its potential benefits, and despite a paucity of
evidence, rapid intravenous rehydration has gradually become
incorporated into clinical practice
9 and is recommended in a
leading textbook of emergency medicine.
10 This procedure,
however, is not without risks. A recent study of fluid bolus
resuscitation in febrile African children had to be stopped early
becauseofincreasedmortalityinthebolusgroup.
11 12Moreover,
advocatesforrapidintravenousrehydration
4suggestthatserum
should be routinely tested to enable the detection of severe
hyponatraemia or hypernatraemia, which necessitates specific
therapeutic approaches to reduce the risk of central pontine
myelinolysis and cerebral oedema, respectively. As only 30%
ofacademicpaediatricemergencymedicinephysiciansroutinely
check electrolytes in the United States,
9 the widespread use of
rapid intravenous rehydration might place children at
unnecessary risk. Given the established safety of standard
rehydration in haemodynamically stable children, the lack of
evidence of benefit, and the potential complications that might
arise with the widespread use of rapid intravenous rehydration,
a rigorous evaluation of this more aggressive approach is
needed.
1
We carried out a pragmatic randomised, blinded, comparative
effectiveness trial among haemodynamically stable children in
whom oral rehydration had failed and who were deemed to
require intravenous rehydration. Our primary objective was to
determinewhethertreatmentwithrapidintravenousrehydration
resulted in a clinically important increase in the number of
children achieving rehydration compared with standard
treatment.
Methods
Patients
Participants were recruited between December 2006 and April
2010 in the emergency department of The Hospital for Sick
Children, Toronto, Canada. Eligibility was designed to enable
the participation of typical children for whom intravenous
rehydrationisadministeredinNorthAmerica.Eligiblechildren
were aged over 90 days, had a diagnosis of dehydration
secondary to gastroenteritis, had not responded to oral
rehydration,
7 and had been prescribed intravenous rehydration.
Dehydration was defined as a clinical dehydration scale score
of>3(table1⇓).Thisfouritemscalehaspreviouslybeenshown
to have good inter-rater reliability (intraclass correlation
coefficient=0.77, 95% confidence interval 0.68 to 0.86) and
discriminatory power (Ferguson’s δ=0.83, 0.77 to 0.88).
13
Subsequent prospective validation has shown that it correlates
with length of stay and the need for intravenous rehydration.
14
It has also been validated independently in two emergency
departments.
15 We excluded children who weighed <5 kg or
>33 kg, required fluid restriction, had a suspected surgical
condition, had a history of a severe chronic systemic disease,
abdominalsurgery,orbiliousorbloodyvomit,hadhypotension,
hypoglycaemia or hyperglycaemia. We also excluded children
of parents/guardians in whom there was an insurmountable
language barrier or who lacked a telephone for follow-up.
Normal biochemical variables were not an entry requirement
as they are not routinely available at the start of intravenous
rehydration. A record of patients missed was kept to assess for
enrolment bias.
Randomisation and masking
Patients were allocated in a 1:1 ratio to treatment with standard
or rapid intravenous rehydration. The permuted block
randomisation sequence was computer generated and stratified
by severity of dehydration (clinical dehydration scale score 3-4
v 5-8). The sequence was concealed from the research nurses
in sequentially numbered sealed opaque envelopes prepared by
an independent coordinator. The envelopes were provided to
the research nurse once consent had been obtained. They were
opened sequentially after information on the participant was
written on the appropriate envelope. The randomisation code
remainedsecureduntilenrolmentanddataentrywerecomplete.
Theresearchnurse,attendingphysicians,andparticipantswere
blinded to treatment allocation. The bedside nurse, who was
unblinded to set the intravenous rate, received instructions not
tocommunicateanyinformationabouttheinfusionorthechild’s
clinicalstatus.Opaquecoverswereusedtoconcealtheinfusion
bags and tubing, and soundproof (Quiet Barrier HD,
Chambersburg, PA) boxes were constructed by the department
of medical engineering to conceal the intravenous pumps.
Attending physicians were blinded to the scores on the clinical
dehydration scale assigned by the research nurse.
Intervention
Before randomisation, all potentially eligible children were
given oral rehydration treatment. Caregivers were instructed to
administer5mLofaflavouredoralrehydrationsolutionthrough
a syringe every five minutes.
7 The rate was increased based on
tolerance and the child’s weight.
7 For children with persistent
vomiting, ondansetron was administered orally in an attempt to
prevent the need for intravenous rehydration.
16-18 A research
nurse was present to recruit patients from 8 am to midnight;
overnight coverage was provided by the principal investigator.
After insertion of an intravenous catheter and the performance
of baseline biochemical tests, the bedside nurse set the
intravenous rate in accordance with the randomisation
assignment. The appearance of infusion pump set ups was
identical in all children. Two 1 L bags of 0.9% saline were
individuallyconnectedto150mLthreeinjectionPORTburette
sets (Alaris Medical Systems, San Diego, CA). Imed Gemini
PC-2TX infusion pumps (Alaris Medical Systems) controlled
the infusion rate. The burette sets were attached first to a Y
connector extension set (MedRx, Largo, FL; length 10 cm;
volume 0.65 mL) and then to a T connector extension set
(Baxter, Deerfield IL; length 15.2 cm; housing volume 0.20
mL; total volume 0.50 mL). The latter was connected to the
intravenous catheter.
Children received either a 20 mL/kg (standard)
9 19 or 60 mL/kg
(rapid) 0.9% saline infusion over 60 minutes followed by 5%
dextrose in 0.9% saline
20 at a maintenance rate.
21 Potassium
chloridewasaddedbasedontheserumpotassiumconcentration:
0 mEq/L if >5.0 mmol/L; 20 mEq/L if 4.0-5.0 mmol/L; 40
mEq/L if <4.0 mmol/L. Caregivers were instructed to continue
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RESEARCHoral rehydration throughout the study period. Every 30 minutes
theresearchnursedocumentedclinicaloutcomes,includingthe
clinical dehydration score, vital signs, success of oral
rehydration, and adverse events. The latter included the
development of fluid overload represented by tachypnoea
(increase greater than 20 breaths per minute from baseline),
tachycardia (increase greater than 20 beats per minute from
baseline, after adjustment for fever), peripheral oedema, and
hypoxia (decrease in transcutaneous oximetry greater than 5%
from baseline). If adverse events were suspected, the attending
physician determined their presence and clinical relevance.
Dysnatraemias,definedasarepeatserumsodiumconcentration
<130 mmol/L or >150 mmol/L, or a value outside the range of
normal (135-145 mmol/L) associated with a change of greater
than 5 mmol/L from baseline, were also considered an adverse
event. A data and safety monitoring board met twice to review
data in a blinded manner and evaluated all adverse events. The
protocol terminated four hours after the start of intravenous
rehydration, at which time biochemical tests were repeated.
Subsequent management decisions (discharge, observation,
admission) were at the discretion of the attending physician.
We used a standardised telephone script to collect follow-up
information on days three and seven after randomisation.
Hospital records were reviewed to confirm caregivers’ reports.
If contact was not made on the designated day, attempts were
continued daily for two weeks.
Outcome measurements
Primary outcome
The primary outcome was rehydration, defined as a score on
the clinical dehydration scale of ≤1
13 14 two hours after the start
oftreatment.Thisscale,whichconsistsoffourclinicalvariables,
was used to improve diagnostic characteristics
22 as individual
measures, such as prolonged capillary refill, abnormal skin
turgor, and abnormal respiratory pattern, have sensitivities of
only 43-60% to detect 5% dehydration.
22 In validation studies,
the scale selected has been shown to correlate with length of
stayandtheuseofintravenousrehydrationandthereforeseems
to correlate with clinical decision making.
14 15
Secondary outcomes
Secondaryoutcomesincludedprolongedtreatment—acomposite
measure defined as admission to an inpatient unit at the index
visit or admission within 72 hours of randomisation or a stay
in the emergency department longer than six hours after the
start of treatment; score on the clinical dehydration scale;
adequate oral intake, a common prerequisite for discharge,
9
defined as consuming at least 5 mL/kg of liquid per two hour
timeperiod(onlyasmallvolumewasprespecifiedasallchildren
additionally received intravenous rehydration); time to
discharge, determined by chart review—defined as the time
betweenthestartoftreatmentanddischargefromtheemergency
departmentorinpatientunit;repeatemergencydepartmentvisit
within 72 hours; and attending physician’s comfort with
discharge at two and four hours as reported on a 5 point Likert
scale. We found the latter correlated strongly with the outcome
of hospital admission.
Sample size
We estimated that enrolling 226 children would provide 80%
power to detect a 20 percentage point difference in the
proportion of children rehydrated two hours after the start of
treatment, given a two sided type I error probability of 0.05 and
a 40% success rate in the standard group. This calculation
included a 5% adjustment for losses to follow-up, withdrawals,
and missing data.
23
Statistical analysis
All analyses followed the intention to treat principle and
included patients with protocol deviations. Analyses were
performed with SAS software (version 9.1), with two sided
significance tests at the 5% significance level for the primary
outcome measure and, to adjust for multiple testing, the 1%
significance level for secondary outcome measures. We also
performed a sensitivity analysis excluding patients with
deviations from the study protocol.
Primary and secondary analyses
We used Fisher’s exact test to examine the difference in the
primary outcome between groups and for the dichotomous
secondary outcomes of prolonged treatment, adequate oral
intake, and repeat visits to the emergency department.
Rehydration at two hours and prolonged treatment were also
analysed with multiple logistic regression models. Potential
covariates identified a priori for rehydration at two hours were
weight, administration of ondansetron, randomisation time,
volumesofdiarrhoea,vomiting,andoralrehydrationconsumed
(mL/kg) as well as baseline bicarbonate concentration, pH, and
score on clinical dehydration scale. For the outcome of
prolonged treatment we additionally considered a history of
previous intravenous rehydration during the current illness and
bicarbonateconcentration,pH,andscoreonclinicaldehydration
scale at four hours instead of baseline parameters. Because of
sample size limitations and to avoid overfitting, the effect of
these potential covariates was determined individually in
univariate analysis. We considered those associated with the
outcomes at a level of significance of <0.20 for inclusion in
multiple logistic regression models provided they were not
highly correlated with other variables.
We compared the clinical dehydration scores between groups
at each 30 minute time point with the use of a mixed model
repeated measures analysis of variance with adjustment for the
baseline score. The median test was used to compare median
times to discharge. The attending physician’s comfort with
discharge was analysed with a Cochrane test for linear trend.
Other analyses
We used Fisher’s exact test for proportions or the t test for
continuous variables, unless otherwise specified, to compare
characteristics at four hours. The difference in biochemical
parameters at four hours was evaluated with analysis of
covariance with the baseline value serving as the covariate.
Rehydration for children with moderate to severe dehydration
(score ≥5) was analysed with Fisher’s exact test.
Results
Participants
Between December 2006 and April 2010, we screened 785
children for participation; 278 met enrolment criteria, and 226
were enrolled, 114 to rapid rehydration and 112 to standard
rehydration (fig 1⇓). A total of 507 children did not meet the
eligibility criteria (see table A in appendix on bmj.com).
Protocol deviations were uncommon (14 patients) and equally
distributedbetweengroups.Baselinecharacteristicsweresimilar
across treatment groups (table 2⇓). Only the primary (intention
to treat) analysis is reported because the results were
qualitatively similar to those of the sensitivity analysis.
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RESEARCHPrimary outcome
Attwohours,36%(41/114)ofchildrengivenrapidintravenous
rehydration and 29% (33/112) of those given standard
rehydration were rehydrated (absolute difference for rapid v
standard 6.5%, 95% confidence interval −5.7% to 18.7%;
P=0.32). The point estimate of the absolute difference
corresponds to 15 children needing to be treated for one child
to achieve rehydration at two hours (number needed to treat).
We repeated the primary analysis after controlling for baseline
weight, score on clinical dehydration scale, and serum pH.
Logistic regression analysis showed no significant association
between treatment assignment and successful rehydration at
two hours (odds ratio 1.8, 0.90 to 3.5; P=0.10, in favour of the
rapid group).
Secondary outcomes
Tables 3 and 4 give details of the secondary outcomes⇓⇓.
Overall, 52% (59/114) in the rapid rehydration group and 43%
(48/112) in the standard group underwent prolonged treatment
(absolutedifferenceforrapidvstandard,8.9%,21.0%to−5.0%;
P=0.19). Logistic regression analysis showed no difference
between the groups (odds ratio 0.81, 0.36 to 1.8; P=0.61, in
favour of the standard group).
There were no significant differences in the mean scores on the
clinical dehydration scale over time (P=0.96; fig 2⇓) or in the
proportions of children rehydrated at four hours (69% (79/114)
and69%(77/112)intherapidandstandardgroups,respectively;
absolutedifferenceforrapidvstandard0.5%,−12.6%to11.5%;
P>0.99). Groups were similar in the proportions who achieved
adequacyoforalintake(table3⇓)andthereasonsforadmission
as stated by the attending physicians (see table B in appendix
onbmj.com).Morechildrenintherapidintravenousrehydration
group were admitted to hospital at the index visit (33 v 19,
P=0.04)(table3)⇓.Thisdifferencepersistedwhenweexcluded
from the analysis the children admitted to hospital because of
their metabolic acidosis (number needed to harm = 9, 4 to 57).
Childrenadmittedtohospitalhadsimilarunadjustedmeanscores
ontheclinicaldehydrationscaleintherapid(n=33)andstandard
(n=19) groups at time 0 (4.9 (SD 1.2) v 4.9 (SD 1.2); P=0.90)
and four hours (2.0 (SD 1.5) v 2.1 (SD 1.7); P=0.82),
respectively. Although time to discharge was slightly higher in
the rapid rehydration group, this did not achieve significance
(6.3 hours v 5.0 hours; P=0.03). There was a trend in favour of
standard rehydration in physician’s comfort with discharge
(table 3⇓), and there were no differences between groups in the
need for repeat visits (table 5⇓).
Other analyses
The most clinically important biochemical difference was the
change in serum bicarbonate (0.56 (SD 1.9) v −0.31 (2.2)
mmol/L; standard v rapid; P=0.01) (table 4⇓). After adjustment
for baseline values, the values at four hours differed by 1.1
mmol/L.Additionalfluidboluseswereadministeredto16(14%)
children who received standard and 11 (10%) who received
rapid intravenous rehydration (P=0.31). Subgroup analysis of
children with baseline scores ≥5 on the clinical dehydration
scale showed no difference between groups in the proportions
who achieved rehydration at two hours (16% rapid v 15%
standard; absolute difference for rapid v standard rehydration
0.7%, −14.3% to 15.9%; P>0.99).
One child in each group developed an interstitial displacement
of the intravenous catheter, which resulted in the administered
fluids entering the immediate surrounding tissue. Unblinding
wasperformedforonechildintherapidintravenousrehydration
group whose baseline serum sodium concentration was 114
mmol/L. One child in each group developed a dysnatraemia:
one child who received rapid rehydration had a decrease in
serum sodium concentration from 138 mmol/L to 130 mmol/L
and one child who received standard rehydration experienced
a decrease in concentration from 130 mmol/L to 128 mmol/L.
Oedemawasreportedinfourchildreninthestandardgroupand
two in the rapid group (P=0.44). No other safety concerns were
reported.
Discussion
There is no difference in clinical effectiveness with rapid or
standard intravenous rehydration for the treatment of
dehydration in children with gastroenteritis. Despite the
increasing adoption of this intervention into routine clinical
care,
1 9 we found that two hours after the initiation of rapid
intravenous rehydration, the resolution of dehydration was
similar to that achieved with standard treatment. Of interest,
and of borderline significance after adjustment for multiple
comparisons, children administered rapid intravenous
rehydration were more commonly admitted to hospital at the
index visit and received longer periods of intravenous
rehydration. None of the outcome measures favoured the use
of rapid intravenous rehydration, and there was a trend toward
worse outcomes in the rapid intravenous rehydration group,
calling into question its use.
Comparison with other studies
The results of our study are important as the literature contains
apaucityofhighqualitystudiesthatshowthatrapidintravenous
rehydration is effective. The most rigorous to date was an
unblinded randomised clinical trial that compared outcomes in
45 children administered 50 mL/kg of 0.9% saline over one
hour with 43 children given the same volume over three hours.
5
Whiletheauthorsconcludedthatrapidintravenousrehydration
is “efficacious,” this outcome measure was not clearly defined.
As this was a pilot study, according to the authors, a post hoc
power analysis was conducted that showed that it had only a
60%powerfordetectingaclinicallyrelevantdifferencebetween
groups. Lastly, while the rate of fluid administration was
evaluated, the volume of fluid administered was the same in
both groups, and as the study was unblinded the authors could
not objectively evaluate the impact of rapid intravenous
rehydration on clinical dehydration status or decision making.
While several non-randomised studies have described cohorts
of children who underwent rapid rehydration, the participants
either had severe dehydration
24-27 or were administered fluid
boluses similar to our standard group.
28-30 A single study
evaluated the ability of rapid intravenous and rapid nasogastric
rehydration (50 mL/kg of 0.9% saline versus Pedialyte (Abbot
Laboratories, Columbus, OH, over three hours) to successfully
treatchildrenwithmoderatedehydration.
31Whilebothtreatment
protocols were found to be safe and efficacious, the serum
bicarbonate concentration in the nasogastric rehydration arm
increasedby1.8mmol/L,whilethoseadministeredintravenous
rehydration experienced a decline of 0.2 mmol/L (P<0.001).
Furthermore, the urine specific gravity dropped to a normal
level faster in the nasogastric arm than in the rapid intravenous
rehydration arm (P=0.02). Although the authors assumed that
morechildrenadministeredrapidintravenousrehydrationwould
bereadyfordischargeatthreehours,nodifferencewasdetected.
Althoughnostandardisedrapidintravenousrehydrationstrategy
exists, a survey of North American physicians who specialise
in paediatric emergency medicine found that various regimens
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9Giventhatwefoundnobenefitwithourintervention,
which is more aggressive than most rapid intravenous
rehydration strategies, our findings can be generalised to those
who use smaller fluid boluses (such as 40 mL/kg).
32 There are
several possible explanations as to why the use of rapid
intravenous rehydration did not result in improved clinical
outcomes. The most plausible physiological explanation could
be the clinical impact of metabolic acidosis induced by large
volume 0.9% saline administration. Although the development
of a hyperchloraemic acidosis seems counterintuitive, it has
previously been described in children with gastroenteritis
5 26 31
and those undergoing general anaesthesia.
33 34 The worsening
acidosis, which is caused by a reduction in the anion gap from
the excessive rise in plasma chloride and excessive renal
elimination of bicarbonate,
35 has been associated with fatigue,
impaired abstract thinking, and abdominal pain.
36
Other potential explanations could include the existence of a
time lag between intravascular volume repletion and the
resolutionofclinicaldehydration,orthattheclinicaldehydration
scale overestimated the severity of dehydration in our study
population. While no data are available to support the former
hypothesis,thedehydrationscaleusedhaspreviouslyperformed
well in evaluating children similar to those enrolled in our
study.
13-15 The scale, however, might have overestimated the
severity of dehydration in some children, as our standard
rehydration protocol (20 mL/kg) was sufficient to rehydrate
many of the study participants.
In addition to lacking evidence of effectiveness, the routine use
of intravenous fluid bolus treatment should be reconsidered as
children initially diagnosed with gastroenteritis might have
alternative or coexistent disease processes that, when treated
with rapid intravenous rehydration, might result in important
complications.Examplesincludepatientswithmyocarditiswho,
if given excessive volumes of intravenous fluids, can suddenly
decompensate
37-40 and those with diabetic ketoacidosis
39 and
diabetes insipidus
40 who can develop cerebral oedema.
Strengths and limitations
The strengths of this study include the rigorous measures used
toensureblindingandminimisetheriskofbias.Moreover,this
was a large pragmatic study that included patients typical of
those who receive intravenous rehydration in developed
countries, thus supporting the generalisability and external
validity of our findings. Because of the diagnostic imprecision
ofavailableclinicalcharacteristicsusedinassessingdehydration
and the poor sensitivity of individual features such as capillary
refill time (lower 95% confidence limit 29%),
22 we used a four
item clinical scale to maximise the probability of enrolling
moderately dehydrated children. This resulted in the exclusion
of131childrenwhoweregivenintravenousrehydrationbutdid
not meet the criteria for severity of dehydration. Nevertheless,
weprobablyenrolledsomechildrenwithmilddehydration.The
inclusion of this group enhances the pragmatic nature of this
trialasourstudypopulationissimilartothoseincludedinother
intravenous rehydration studies in developed countries,
41-44 and
hence are candidates for rapid intravenous rehydration.
Furthermore, subgroup analysis did not show a trend towards
increased benefit in children with more severe dehydration.
Although, in certain regions, alternative rehydration strategies
such as persistence with oral rehydration or the use of
nasogastric fluid treatment might be more commonly used, we
aimed to conduct a pragmatic trial in keeping with current
practice patterns.
9 Because of ethical and logistical reasons we
didnotstudychildrenwithcompromisedcardiovascularstability
so our results cannot be generalised to such children. Lastly,
wedidnotblindtheattendingphysicianstotherepeatelectrolyte
results, which could have influenced the final outcome. The
attending physician’s level of comfort with discharge at four
hours, however, was assigned before the availability of the
repeat laboratory results and no difference between groups was
detected. Moreover, the same numbers of children (n=3) were
admitted in each study arm primarily because of the severity of
their metabolic acidosis.
Conclusions and policy implications
In summary, our study of haemodynamically stable children
with gastroenteritis who were deemed to require intravenous
rehydration found no beneficial clinical effects from the
administration of rapid intravenous rehydration. Given the
potential risks associated with this approach, its routine use in
such children should be reconsidered.
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RESEARCHTables
Table 1| Clinical dehydration scale* used in children with gastroenteritis
Score category
Characteristic 2 1 0
Drowsy, limp, cold or sweaty, comatose Thirsty, restless, or lethargic but irritable
when touched
Normal General appearance†
Very sunken Slightly sunken Normal Eyes
Dry Sticky Moist Mucous membranes‡
Absent Decreased Present Tears
*Higher scores indicate more severe dehydration. Scores range from 0 to 8. Scores 0=<3% dehydration (positive likelihood ratio 2.2, 95% confidence interval 0.9
to 5.3), scores 1-4=some (3-6%) dehydration (1.3, 0.9 to 1.7), and scores 5-8=moderate to severe (≥6%) dehydration (5.2, 2.1 to 12.8).
45
†“Normal” includes children who might be sleeping but are easily aroused to normal level of consciousness. Takes into account time of day and child’s usual
pattern as described by child’s parent/guardian.
‡Assessed on buccal mucosa and tongue, and not lips.
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RESEARCH| Table 2 Baseline characteristics in children with gastroenteritis according to different methods of intravenous rehydration.* Figures are
means (SD) unless stated otherwise
Standard intravenous rehydration (n=112) Rapid intravenous rehydration (n=114) Characteristic
2.4 (1.3-4.2) 2.2 (1.4-3.8) Median (IQR) age (years)†
14.2 (5.4) 13.4 (4.9) Weight (kg)
Serum values at catheterisation:
136.7 (3.8) 136.3 (4.2) Sodium (mmol/L)
4.3 (0.6) 4.2 (0.7) Potassium (mmol/L)
18.1 (3.5) 18.0 (3.9) Bicarbonate (mmol/L)
23 (21) 31 (27) No (%) with bicarbonate ≤15 mmol/L
5.4 (2.2) 5.7 (3.1) Blood urea nitrogen (mmol/L)
35.0 (8.5) 36.3 (11.2) Creatinine (μmol/L)
4.5 (1.4) 4.6 (1.3) Glucose (mmol/L)
7.37 (0.06) 7.36 (0.06) pH
Clinical characteristics:
38.1 (0.7) 38.1 (0.6) Temperature (°C)
27 (6) 28 (6) Respiratory rate (breaths/min)
127 (20) 127 (20) Heart rate (beats/min)
98 (1) 99 (1) Oxygen saturation (%)
4.5 (1.2) 4.5 (1.2) Clinical dehydration scale score‡
47 (42) 45 (40) No (%) with clinical dehydration scale score ≥5
0.82 (0.42) 0.86 (0.42) Capillary refill time (sec)
43 (38) 41 (36) No (%) with previous visit to emergency department
44 (39) 43 (38) No (%) who received ondansetron in emergency department
IQR=interquartile range.
*No significant differences between groups.
†Age distribution non-parametric; compared with median test.
‡Higher values indicate more severe dehydration.
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RESEARCHTable 3| Secondary outcomes over time according to different methods of rehydration in children with gastroenteritis. Figures are numbers
(percentage) of children unless stated otherwise
P value*
Standard intravenous rehydration
group (n=112)
Rapid intravenous rehydration group
(n=114)
0.18 48 (43) 59 (52) Prolonged treatment†
0.04 19 (17) 33 (29) Hospital admission at initial visit
0.78 37 (33) 40 (35) Emergency department length of stay >6 hours
0.77 5 (5) 7 (6) Revisit resulting in admission
Adequacy of oral intake‡:
0.31 36 (32) 29 (25) 5 mL/kg at 2 hours
0.69 46 (41) 50 (44) 5 mL/kg at 4 hours
0.54 15 (13) 13 (11) 10 mL/kg at 2 hours
0.87 24 (21) 25 (22) 10 mL/kg at 4 hours
0.86 4.1 (4.5) 4.0 (6.3) Mean (SD) volume consumed (mL/kg), 0-2
hours
0.23 5.9 (6.2) 7.2 (9.8) Mean (SD) volume consumed (mL/kg), 0-4
hours
0.20 14 (13) 22 (19) Vomited during 4 hour study period
Physician was comfortable with discharge§:
0.07 42 (38) 30 (26) 2 hours
0.06 74 (66) 61 (54) 4 hours
Emergency department revisits¶:
0.69 13 (12) 16 (14) Within 3 days
0.72 19 (17) 17 (15) Within 7 days
*For comparisons of standard with rapid intravenous rehydration.
†Composite outcome measure defined as any of: admission to hospital at initial visit, stay of >6 hours after start of intravenous treatment, or revisit resulting in
admission within 72 hours of start of treatment.
‡Defined a priori as consuming at least 5 mL/kg of liquid per 2 hour time period.
§Physicians determined to be comfortable with discharge if they either “strongly agreed” or “agreed,” on 5 point Likert scale, that child was ready for discharge at
indicated time points. P values represent analysis of responses with Cochrane test for linear trend.
¶No of children contacted on day 3: 114 in rapid rehydration group; 111 in standard rehydration group. No of children contacted on day 7: 114 and 109, respectively.
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RESEARCHTable 4| Clinical and biochemical characteristics over time according to different methods of rehydration in children with gastroenteritis*.
Figures are means (SD) unless stated otherwise
P value*
Standard intravenous rehydration
(n=112) Rapid intravenous rehydration (n=114)
Serum values, time 4 hours (least squares means)†:
0.06 137.5 (2.0) 138.0 (2.0) Sodium (mmol/L)
0.01 3.9 (0.48) 3.8 (0.48) Potassium (mmol/L)
<0.001 18.5 (2.1) 17.4 (2.1) Bicarbonate (mmol/L)
<0.001 4.1 (1.7) 3.8 (2.0) Blood urea nitrogen (mmol/L)
0.003 33.1 (8.1) 32.3 (8.2) Creatinine (μmol/L
0.20 5.1 (1.2) 5.4 (1.6) Glucose (mmol/L)
0.10 7.35 (0.04) 7.34 (0.04) pH
Clinical characteristics:
Respiratory rate (breaths/min):
0.14 25 (5) 27 (6) 120
0.09 25 (5) 26 (5) 240
Heart rate (beats/min):
0.17 125 (19) 122 (19) 120
0.13 118 (17) 121 (16) 240
<0.001 1.9 (3.2) 3.9 (3.9) % Weight change between time 0 and 4 hrs
*For comparisons of standard with rapid intravenous rehydration.
†Obtained in 219 children for sodium; 218 for potassium; 214 for bicarbonate; 216 for blood urea nitrogen; 218 for creatinine; 211 for glucose; 172 for pH.
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RESEARCHTable 5| Follow-up data* according to different methods of rehydration in children with gastroenteritis. Figures are numbers (percentage)
of children unless stated otherwise
Standard intravenous rehydration (n=112) Rapid intravenous rehydration (n=114) Variable
Follow-up on day 3
111/112 (99) 114/114 (100) Completed follow-up
3.7 4.1 Mean interval between enrolment and follow-up (days)
13/111 (12) 16/114 (14) Return visit to emergency department
5/111 (5) 10/114 (9) Intravenous rehydration
5/111 (5) 7/114 (6) Hospital admission
Follow-up on day 7
109/112 (97) 114/114 (100) Completed follow-up
8.3 8.2 Mean interval between enrolment and follow-up (days)
7/109 (6) 1/114 (1) Return visit to emergency department
5/109 (5) 1/114 (1) Intravenous rehydration
3/109 (3) 0/114 (0) Hospital admission
Follow-up on both days
19/109 (17) 16/114 (14) Any return visit to emergency department
10/109 (9) 11/114 (10) Any intravenous rehydration
*There were no significant (P<0.01) differences between groups.
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RESEARCHFigures
Fig 1 Eligibility, randomisation, and follow-up of study participants. Data were available for all 226 infants for primary outcome
of rehydration at two hours
Fig 2 Score on clinical dehydration scale as continuous variable analysed with repeated measures analysis of variance
(ANOVA) adjusted for baseline score in children allocated to standard or rapid intravenous rehydration. Time 0 represents
all children at the start of rehydration protocol. Data for each time point represent mean score with 95% confidence intervals,
as recorded by research nurse every 30 minutes until completion of protocol at 240 minutes (four hours). No significant
difference between groups in scores through study period (P=0.96)
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